| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/15/2005 | CN1626140A Medication for treating obstruction of qi in the chest |
| 06/15/2005 | CN1626138A Medication for treating coronary heart disease and angina |
| 06/15/2005 | CN1626133A Medication for treating coronary heart disease |
| 06/15/2005 | CN1626132A Medication for treating obstruction of qi in the chest |
| 06/15/2005 | CN1626131A Medication for treating coronary heart disease and angina |
| 06/15/2005 | CN1626130A Medication for treating toothache |
| 06/15/2005 | CN1626129A Medicine for treating obstruction of qi in the chest and heartache |
| 06/15/2005 | CN1626122A Medication for treating cardiovascular and cerebrovascular diseases |
| 06/15/2005 | CN1626121A Preparation of Chinese traditional medicine for treating coronary heart disease and angina |
| 06/15/2005 | CN1626117A Method for preparing pills |
| 06/15/2005 | CN1626115A Spray agent of dried powder in use for treating hemorrhoid and preparation method |
| 06/15/2005 | CN1626113A Hygienical fermented wine for preventing cardiovascular diseases |
| 06/15/2005 | CN1626097A Cyclovirobuxine D oral desintegration tablet and prepartion method |
| 06/15/2005 | CN1626096A Huangyangning drop pills and preparation method |
| 06/15/2005 | CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 06/15/2005 | CN1626086A Urapidil powder and injection preparation and preparing method |
| 06/15/2005 | CN1626085A Levosimendan freeze-dried preparation and preparing method |
| 06/15/2005 | CN1626075A Combination of medication and application of preparing medication for treating or preventing cardiovascular and cerebrovascular diseases |
| 06/15/2005 | CN1626071A Propylgallate injection administration does type and preparation method |
| 06/15/2005 | CN1626069A Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy |
| 06/15/2005 | CN1626067A Preparation of honokiol, magnolol or their admixture and usage in preparing medication for treating cardiovascular and cerebrovascular diseases |
| 06/15/2005 | CN1625965A Soluble soy protein with superior functional properties |
| 06/15/2005 | CN1625964A Capsule of natural protein containing selenium and American ginseng |
| 06/15/2005 | CN1206363C Process for obtaining of HMG-CO a reductase inhibitors of high purify |
| 06/15/2005 | CN1206236C Manyprickle acanthopanax general saponin extractive and its medicinal composition |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1206213C N-arylsulfonyl amino acid omega amides |
| 06/15/2005 | CN1206212C Tri-substd. phenyl derivs. and analogues |
| 06/15/2005 | CN1206133C Infusion packet and its use |
| 06/15/2005 | CN1205982C drop liquid for treating angiocardiopathy |
| 06/15/2005 | CN1205977C Chinese medicinal herb preparation for cardivascular diseases |
| 06/15/2005 | CN1205951C Composite medicine for treating hircus, tinea and external piles |
| 06/15/2005 | CN1205941C Puerarin oral preparation and its preparation method |
| 06/15/2005 | CN1205940C Erigeron breviscapus slow release capsule and its preparation method |
| 06/15/2005 | CN1205938C Products having function of improving microcirculation action of mammal |
| 06/15/2005 | CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient |
| 06/15/2005 | CN1205928C Application of xanthiphenylketamine or its salt in preparing medicines to treat cardiovascular disease |
| 06/14/2005 | US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof |
| 06/14/2005 | US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 06/14/2005 | US6906092 Method of inhibiting matrix metalloproteinases |
| 06/14/2005 | US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents |
| 06/14/2005 | US6906084 Indole derivatives as factor Xa inhibitors |
| 06/14/2005 | US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture |
| 06/14/2005 | US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH |
| 06/14/2005 | US6906072 Central nervous system disorders |
| 06/14/2005 | US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 06/14/2005 | US6906063 For therapy and prophylaxis of thrombosis in a mammal |
| 06/14/2005 | US6906059 Administering cardioprotective amount of a benzazepin-N-acetic acid derivative for inhibiting or treating heart damage induced by a cardiotoxic medicamet in a mammal |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906051 Viricides, fungicides, microbiocides, osteoporosis |
| 06/14/2005 | US6905704 Animal extracts; hypotensive agent; storage stability |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905678 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 06/14/2005 | US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/14/2005 | CA2274591C Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 06/14/2005 | CA2163122C Positive inotropic and lusitropic pyrroloquinolinone derivatives |
| 06/09/2005 | WO2005051913A1 Cyclic amine derivative having heteroaryl ring |
| 06/09/2005 | WO2005051912A1 Piperidine compound and method for producing same |
| 06/09/2005 | WO2005051404A1 Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases |
| 06/09/2005 | WO2005037198A3 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors |
| 06/09/2005 | WO2005021003A3 Immunosuppressive effects of pteridine derivatives |
| 06/09/2005 | WO2005018564A3 Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage |
| 06/09/2005 | WO2005009276A3 Microbial cellulose wound dressing |
| 06/09/2005 | WO2004043956A8 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 06/09/2005 | WO2004043383A8 A new target for angiogenesis and anti-angiogenesis therapy |
| 06/09/2005 | WO2004012671A3 Substituted furo [2,3-b] pyridine derivatives |
| 06/09/2005 | US20050124862 Thyroid hormone analogs and methods of use |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124793 Novel proteins and dnas thereof |
| 06/09/2005 | US20050124696 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 06/09/2005 | US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma |
| 06/09/2005 | US20050124632 Use of aminobenzenesulfonic acid derivative or a salt, hydrate, or solvate thereof; treatment of heart failure or arrhythmia in diabetic ischemic heart disease |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/09/2005 | US20050124627 Use as excitatory amino acid antagonists for combating neurodegenerative and cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's, Parkinson's or Huntington's disease, or psychoses; for example, 3-[4-(3,4-methylenedioxybenzyl)piperidino]-N-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propionamide |
| 06/09/2005 | US20050124624 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 06/09/2005 | US20050124606 Novel benzothiazine and benzothiadiazine derivatives method for preparing same and pharmaceutical compositions containing same |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124586 Alpha-substituted arylalkyl phosphonate derivatives |
| 06/09/2005 | US20050124581 Alpha-substituted heteroarylalkyl phosphonate derivatives |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124574 Purine derivatives |
| 06/09/2005 | US20050124558 Controlling particle size; bioavailability |
| 06/09/2005 | US20050124554 Spermidine derivatives for the treatment of chronic neurodegenerative diseases |
| 06/09/2005 | US20050124541 Improving heart function by increasing venturicular contaction using growth hormone |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124036 Method for producing recombinant proteins in micro-organisms |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050123999 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 06/09/2005 | US20050123919 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123671 Incorporating trehalose into an edible aqueous system containing alpha glucosyl hesperidin or catechin or both followed by sterilization |